nAChRs/NMDA Interaction Inhibitor (Centre for Addiction and Mental Health)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamenAChRs/NMDA Interaction Inhibitor (Centre for Addiction and Mental Health)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlutamate [NMDA] receptor modulatorsNicotinic receptors modulators
TargetsGlutamate [NMDA] receptorNicotinic receptors
Therapy Area/IndicationsTobacco Use DisorderAlcoholism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre For Addiction And Mental Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentre For Addiction And Mental Health
Active IndicationsN/A
Inactive IndicationsTobacco Use DisorderAlcoholism

Other Information

ATC CodeN/A
Related LinksN/A